Annual CFF
-$2.20 M
+$5.87 M+72.70%
31 March 2022
Summary:
Abiomed annual cash flow from financing activities is currently -$2.20 million, with the most recent change of +$5.87 million (+72.70%) on 31 March 2022. During the last 3 years, it has risen by +$5.87 million (+72.70%).ABMD Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$110.18 M
-$86.25 M-360.32%
30 September 2022
Summary:
Abiomed quarterly cash flow from financing activities is currently -$110.18 million, with the most recent change of -$86.25 million (-360.32%) on 30 September 2022.ABMD Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$135.53 M
-$116.87 M-626.02%
30 September 2022
Summary:
Abiomed TTM cash flow from financing activities is currently -$135.53 million, with the most recent change of -$116.87 million (-626.02%) on 30 September 2022.ABMD TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABMD Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | +72.7% | -1688.4% | -8467.3% |
| 5 y5 years | +96.0% | -341.7% | -45.8% |
ABMD Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -102.3% | -214.7% | -239.7% |
Abiomed Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$110.18 M(+360.3%) | -$135.53 M(+626.0%) |
| June 2022 | - | -$23.94 M(-604.4%) | -$18.67 M(+747.8%) |
| Mar 2022 | -$2.20 M(-72.7%) | $4.75 M(-177.0%) | -$2.20 M(+39.2%) |
| Dec 2021 | - | -$6.16 M(-192.2%) | -$1.58 M(-127.0%) |
| Sept 2021 | - | $6.68 M(-189.5%) | $5.86 M(+26.8%) |
| June 2021 | - | -$7.47 M(-239.2%) | $4.62 M(-157.3%) |
| Mar 2021 | -$8.07 M(-93.1%) | $5.37 M(+319.5%) | -$8.07 M(-77.1%) |
| Dec 2020 | - | $1.28 M(-76.5%) | -$35.20 M(-42.7%) |
| Sept 2020 | - | $5.45 M(-127.0%) | -$61.42 M(-37.7%) |
| June 2020 | - | -$20.16 M(-7.4%) | -$98.60 M(-16.2%) |
| Mar 2020 | -$117.72 M(+111.1%) | -$21.77 M(-12.7%) | -$117.72 M(+26.7%) |
| Dec 2019 | - | -$24.95 M(-21.4%) | -$92.93 M(+34.5%) |
| Sept 2019 | - | -$31.73 M(-19.2%) | -$69.10 M(+107.8%) |
| June 2019 | - | -$39.28 M(-1401.0%) | -$33.25 M(-40.4%) |
| Mar 2019 | -$55.77 M(+510.4%) | $3.02 M(-370.5%) | -$55.77 M(-0.8%) |
| Dec 2018 | - | -$1.12 M(-127.1%) | -$56.24 M(+5.1%) |
| Sept 2018 | - | $4.12 M(-106.7%) | -$53.52 M(-5.3%) |
| June 2018 | - | -$61.80 M(-2522.6%) | -$56.50 M(+518.4%) |
| Mar 2018 | -$9.14 M(-336.3%) | $2.55 M(+58.8%) | -$9.14 M(+609.4%) |
| Dec 2017 | - | $1.61 M(+40.9%) | -$1.29 M(-1388.0%) |
| Sept 2017 | - | $1.14 M(-107.9%) | $100.00 K(-84.7%) |
| June 2017 | - | -$14.43 M(-238.8%) | $655.00 K(-83.1%) |
| Mar 2017 | $3.87 M(-46.0%) | $10.40 M(+247.4%) | $3.87 M(-183.3%) |
| Dec 2016 | - | $2.99 M(+76.6%) | -$4.64 M(-37.0%) |
| Sept 2016 | - | $1.70 M(-115.1%) | -$7.36 M(+39.6%) |
| June 2016 | - | -$11.22 M(-693.1%) | -$5.27 M(-173.6%) |
| Mar 2016 | $7.16 M(-24.8%) | $1.89 M(+593.0%) | $7.16 M(+5.6%) |
| Dec 2015 | - | $273.00 K(-92.8%) | $6.78 M(-46.1%) |
| Sept 2015 | - | $3.79 M(+212.8%) | $12.57 M(+15.1%) |
| June 2015 | - | $1.21 M(-20.1%) | $10.93 M(+14.7%) |
| Mar 2015 | $9.52 M(-1.1%) | $1.51 M(-75.0%) | $9.52 M(-0.0%) |
| Dec 2014 | - | $6.06 M(+183.8%) | $9.53 M(+49.5%) |
| Sept 2014 | - | $2.14 M(-1207.3%) | $6.37 M(-19.7%) |
| June 2014 | - | -$193.00 K(-112.7%) | $7.93 M(-17.6%) |
| Mar 2014 | $9.63 M(-181.6%) | $1.52 M(-47.8%) | $9.63 M(+130.2%) |
| Dec 2013 | - | $2.91 M(-21.4%) | $4.18 M(-145.8%) |
| Sept 2013 | - | $3.70 M(+145.8%) | -$9.13 M(-19.2%) |
| June 2013 | - | $1.50 M(-138.3%) | -$11.30 M(-4.4%) |
| Mar 2013 | -$11.81 M(-180.5%) | -$3.93 M(-62.3%) | -$11.81 M(+127.7%) |
| Dec 2012 | - | -$10.41 M(-778.0%) | -$5.19 M(-156.3%) |
| Sept 2012 | - | $1.53 M(+55.1%) | $9.21 M(+14.5%) |
| June 2012 | - | $990.00 K(-63.3%) | $8.04 M(-45.2%) |
| Mar 2012 | $14.68 M(+968.4%) | $2.70 M(-32.3%) | $14.68 M(+14.8%) |
| Dec 2011 | - | $3.99 M(+983.2%) | $12.79 M(+44.1%) |
| Sept 2011 | - | $368.00 K(-95.2%) | $8.88 M(-0.4%) |
| June 2011 | - | $7.63 M(+847.7%) | $8.91 M(+548.4%) |
| Mar 2011 | $1.37 M(+40.3%) | $805.00 K(+1002.7%) | $1.37 M(+67.0%) |
| Dec 2010 | - | $73.00 K(-81.8%) | $823.00 K(-10.7%) |
| Sept 2010 | - | $402.00 K(+327.7%) | $922.00 K(-6.0%) |
| June 2010 | - | $94.00 K(-63.0%) | $981.00 K(+0.2%) |
| Mar 2010 | $979.00 K(-97.9%) | $254.00 K(+47.7%) | $979.00 K(+7.5%) |
| Dec 2009 | - | $172.00 K(-62.7%) | $911.00 K(-49.1%) |
| Sept 2009 | - | $461.00 K(+401.1%) | $1.79 M(-95.9%) |
| June 2009 | - | $92.00 K(-50.5%) | $43.89 M(-5.1%) |
| Mar 2009 | $46.23 M(+2133.3%) | $186.00 K(-82.3%) | $46.23 M(-2.1%) |
| Dec 2008 | - | $1.05 M(-97.5%) | $47.24 M(+4.9%) |
| Sept 2008 | - | $42.56 M(+1647.0%) | $45.02 M(+1333.7%) |
| June 2008 | - | $2.44 M(+103.7%) | $3.14 M(+51.7%) |
| Mar 2008 | $2.07 M(-96.9%) | $1.20 M(-202.0%) | $2.07 M(-96.8%) |
| Dec 2007 | - | -$1.17 M(-272.4%) | $65.50 M(-2.0%) |
| Sept 2007 | - | $680.00 K(-50.2%) | $66.84 M(-0.8%) |
| June 2007 | - | $1.37 M(-97.9%) | $67.36 M(+1.2%) |
| Mar 2007 | $66.56 M | $64.62 M(>+9900.0%) | $66.56 M(+2526.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2006 | - | $177.00 K(-85.1%) | $2.53 M(-0.4%) |
| Sept 2006 | - | $1.19 M(+110.1%) | $2.54 M(+81.5%) |
| June 2006 | - | $567.00 K(-5.3%) | $1.40 M(-33.0%) |
| Mar 2006 | $2.09 M(-48.8%) | $599.00 K(+220.3%) | $2.09 M(+20.0%) |
| Dec 2005 | - | $187.00 K(+281.6%) | $1.74 M(-33.1%) |
| Sept 2005 | - | $49.00 K(-96.1%) | $2.60 M(-5.7%) |
| June 2005 | - | $1.26 M(+403.2%) | $2.76 M(-32.4%) |
| Mar 2005 | $4.09 M(+157.2%) | $250.00 K(-76.1%) | $4.09 M(-15.1%) |
| Dec 2004 | - | $1.05 M(+408.7%) | $4.81 M(+17.4%) |
| Sept 2004 | - | $206.00 K(-92.0%) | $4.10 M(-1.7%) |
| June 2004 | - | $2.58 M(+164.9%) | $4.17 M(+162.6%) |
| Mar 2004 | $1.59 M(+469.5%) | $975.00 K(+191.0%) | $1.59 M(+143.7%) |
| Dec 2003 | - | $335.00 K(+20.1%) | $652.00 K(+115.2%) |
| Sept 2003 | - | $279.00 K(>+9900.0%) | $303.00 K(+27.3%) |
| June 2003 | - | $0.00(-100.0%) | $238.00 K(-14.7%) |
| Mar 2003 | $279.00 K(-44.2%) | $38.00 K(-371.4%) | $279.00 K(-27.2%) |
| Dec 2002 | - | -$14.00 K(-106.5%) | $383.00 K(-14.5%) |
| Sept 2002 | - | $214.00 K(+422.0%) | $448.00 K(-40.1%) |
| June 2002 | - | $41.00 K(-71.1%) | $748.00 K(+49.6%) |
| Mar 2002 | $500.00 K(-16.4%) | $142.00 K(+178.4%) | $500.00 K(-38.1%) |
| Dec 2001 | - | $51.00 K(-90.1%) | $808.00 K(+23.9%) |
| Sept 2001 | - | $514.00 K(-348.3%) | $652.00 K(+101.9%) |
| June 2001 | - | -$207.00 K(-146.0%) | $323.00 K(-46.0%) |
| Mar 2001 | $598.00 K(-99.4%) | $450.00 K(-528.6%) | $598.00 K(-99.4%) |
| Dec 2000 | - | -$105.00 K(-156.8%) | $96.22 M(-0.8%) |
| Sept 2000 | - | $185.00 K(+172.1%) | $97.02 M(+0.1%) |
| June 2000 | - | $68.00 K(-99.9%) | $96.92 M(+0.1%) |
| Mar 2000 | $96.87 M(>+9900.0%) | $96.07 M(>+9900.0%) | $96.87 M(>+9900.0%) |
| Dec 1999 | - | $700.00 K(+757.8%) | $912.50 K(+267.2%) |
| Sept 1999 | - | $81.60 K(+343.5%) | $248.50 K(-63.0%) |
| June 1999 | - | $18.40 K(-83.6%) | $671.30 K(-16.1%) |
| Mar 1999 | $800.00 K(-96.1%) | $112.50 K(+212.5%) | $800.00 K(+1.6%) |
| Dec 1998 | - | $36.00 K(-92.9%) | $787.50 K(-83.8%) |
| Sept 1998 | - | $504.40 K(+242.9%) | $4.85 M(-76.2%) |
| June 1998 | - | $147.10 K(+47.1%) | $20.35 M(+0.2%) |
| Mar 1998 | $20.30 M(+3960.0%) | $100.00 K(-97.6%) | $20.30 M(-0.3%) |
| Dec 1997 | - | $4.10 M(-74.4%) | $20.36 M(+24.7%) |
| Sept 1997 | - | $16.00 M(>+9900.0%) | $16.33 M(+3983.4%) |
| June 1997 | - | $100.00 K(-38.0%) | $400.00 K(-20.0%) |
| Mar 1997 | $500.00 K(+236.2%) | $161.20 K(+122.7%) | $500.00 K(+41.8%) |
| Dec 1996 | - | $72.40 K(+9.0%) | $352.50 K(+18.1%) |
| Sept 1996 | - | $66.40 K(-66.8%) | $298.60 K(-14.4%) |
| June 1996 | - | $200.00 K(+1359.9%) | $348.70 K(+134.5%) |
| Mar 1996 | $148.70 K(>+9900.0%) | $13.70 K(-25.9%) | $148.70 K(+10.1%) |
| Dec 1995 | - | $18.50 K(-84.1%) | $135.00 K(+15.9%) |
| Sept 1995 | - | $116.50 K(>+9900.0%) | $116.50 K(>+9900.0%) |
| June 1995 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1995 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1994 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 1994 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 1994 | - | $0.00(0.0%) | $100.00 K(0.0%) |
| Mar 1994 | $100.00 K(>+9900.0%) | $0.00(0.0%) | $100.00 K(0.0%) |
| Dec 1993 | - | $0.00(-100.0%) | $100.00 K(0.0%) |
| Sept 1993 | - | $100.00 K(>+9900.0%) | $100.00 K(-200.0%) |
| June 1993 | - | $0.00(0.0%) | -$100.00 K(<-9900.0%) |
| Mar 1993 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1992 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 1992 | - | -$100.00 K(-200.0%) | $100.00 K(-50.0%) |
| June 1992 | - | $100.00 K(>+9900.0%) | $200.00 K(+100.0%) |
| Mar 1992 | $100.00 K(-92.9%) | $0.00(-100.0%) | $100.00 K(0.0%) |
| Dec 1991 | - | $100.00 K(>+9900.0%) | $100.00 K(>+9900.0%) |
| Sept 1991 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 1991 | - | $0.00 | $0.00 |
| Mar 1991 | $1.40 M | - | - |
FAQ
- What is Abiomed annual cash flow from financing activities?
- What is the all time high annual CFF for Abiomed?
- What is Abiomed quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Abiomed?
- What is Abiomed TTM cash flow from financing activities?
- What is the all time high TTM CFF for Abiomed?
What is Abiomed annual cash flow from financing activities?
The current annual CFF of ABMD is -$2.20 M
What is the all time high annual CFF for Abiomed?
Abiomed all-time high annual cash flow from financing activities is $96.87 M
What is Abiomed quarterly cash flow from financing activities?
The current quarterly CFF of ABMD is -$110.18 M
What is the all time high quarterly CFF for Abiomed?
Abiomed all-time high quarterly cash flow from financing activities is $96.07 M
What is Abiomed TTM cash flow from financing activities?
The current TTM CFF of ABMD is -$135.53 M
What is the all time high TTM CFF for Abiomed?
Abiomed all-time high TTM cash flow from financing activities is $97.02 M